Psychiatric uses of topiramate: What is the current evidence?
South African Journal of Psychiatry
| Field | Value | |
| Title | Psychiatric uses of topiramate: What is the current evidence? | |
| Creator | Joubert, Pierre M | |
| Description | Topiramate enhances gamma-amino-butyric acid effects, has anti- glutaminergic effects, and is a state-dependent sodium channel blocker. 1 It is registered as an adjunctive treatment for epilepsy but is not registered for psychiatric indications. Nevertheless, it may be useful beyond its initial indication, considering the promising literature on which I report below. However, much more research evidence is needed to establish sufficient scientific justification for prescribing it routinely for psychiatric purposes. | |
| Publisher | AOSIS | |
| Date | 2008-06-01 | |
| Identifier | 10.4102/sajpsychiatry.v14i2.157 | |
| Source | South African Journal of Psychiatry; Vol 14, No 2 (2008); 5 2078-6786 1608-9685 | |
| Language | eng | |
| Relation |
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:
https://sajp.org.za/index.php/sajp/article/view/157/147
|
|
ADVERTISEMENT
